4TEEN4 Pharmaceuticals

About:

4TEEN4 Pharmaceuticals develops innovative biomarkers for diagnosis, prediction and monitoring of acute medical conditions.

Website: https://4teen4.de/

Twitter/X: sphingotec

Top Investors: Wellington Partners, EASME - EU Executive Agency for SMEs, Brandenburg Kapital, HBM Partners, HBM Healthcare Investments

Description:

4TEEN4 Pharmaceuticals GmbH is a biopharmaceutical company developing Procizumab, a humanized antibody targeting human Dipeptidyl Peptidase 3 (DPP3) for the treatment of acute cardiovascular diseases.